TY - JOUR AU - Baek, W. AU - Lee, S. G. AU - Kim, Y. S. AU - Kim, J. H. AU - Jun, J. B. AU - Kim, H. Y. PY - 2012 DA - 2012// TI - Fatal varicella-zoster virus vasculopathy associated with adalimumab therapy JO - Arch Neurol VL - 69 UR - https://doi.org/10.1001/archneurol.2011.3741 DO - 10.1001/archneurol.2011.3741 ID - Baek2012 ER - TY - JOUR AU - Koo, S. AU - Marty, F. M. AU - Baden, L. R. PY - 2010 DA - 2010// TI - Infectious complications associated with immunomodulating biologic agents JO - Infect Dis Clin N Am VL - 24 UR - https://doi.org/10.1016/j.idc.2010.01.006 DO - 10.1016/j.idc.2010.01.006 ID - Koo2010 ER - TY - JOUR AU - Ali, T. AU - Kaitha, S. AU - Mahmood, S. AU - Ftesi, A. AU - Stone, J. AU - Bronze, M. S. PY - 2013 DA - 2013// TI - Clinical use of anti-TNF therapy and increased risk of infections JO - Drug Healthc Patient Saf VL - 5 ID - Ali2013 ER - TY - JOUR AU - Baddley, J. W. AU - Cantini, F. AU - Goletti, D. AU - Gómez-Reino, J. J. AU - Mylonakis, E. AU - San-Juan, R. PY - 2018 DA - 2018// TI - ESCMID study Group for Infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents) JO - Clin Microbiol Infect VL - 24 UR - https://doi.org/10.1016/j.cmi.2017.12.025 DO - 10.1016/j.cmi.2017.12.025 ID - Baddley2018 ER - TY - JOUR AU - Rychly, D. J. AU - DiPiro, J. T. PY - 2005 DA - 2005// TI - Infections associated with tumor necrosis factor-alpha antagonists JO - Pharmacotherapy VL - 25 UR - https://doi.org/10.1592/phco.2005.25.9.1181 DO - 10.1592/phco.2005.25.9.1181 ID - Rychly2005 ER - TY - JOUR AU - Downey, C. PY - 2016 DA - 2016// TI - Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: a literature review JO - Int J Rheum Dis VL - 19 UR - https://doi.org/10.1111/1756-185X.12659 DO - 10.1111/1756-185X.12659 ID - Downey2016 ER - TY - JOUR AU - García-Doval, I. AU - Pérez-Zafrilla, B. AU - Descalzo, M. A. AU - Roselló, R. AU - Hernández, M. V. AU - Gómez-Reino, J. J. PY - 2010 DA - 2010// TI - Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.125658 DO - 10.1136/ard.2009.125658 ID - García-Doval2010 ER - TY - JOUR AU - Strangfeld, A. AU - Listing, J. AU - Herzer, P. AU - Liebhaber, A. AU - Rockwitz, K. AU - Richter, C. PY - 2009 DA - 2009// TI - Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents JO - JAMA VL - 301 UR - https://doi.org/10.1001/jama.2009.146 DO - 10.1001/jama.2009.146 ID - Strangfeld2009 ER - TY - JOUR AU - Tran, C. T. AU - Ducancelle, A. AU - Masson, C. AU - Lunel-Fabiani, F. PY - 2017 DA - 2017// TI - Herpes zoster: risk and prevention during immunomodulating therapy JO - Joint Bone Spine VL - 84 UR - https://doi.org/10.1016/j.jbspin.2016.04.001 DO - 10.1016/j.jbspin.2016.04.001 ID - Tran2017 ER - TY - JOUR AU - Leung, V. S. AU - Nguyen, M. T. AU - Bush, T. M. PY - 2004 DA - 2004// TI - Disseminated primary varicella after initiation of infliximab for Crohn’s disease JO - Am J Gastroenterol VL - 99 UR - https://doi.org/10.1111/j.1572-0241.2004.41389_7.x DO - 10.1111/j.1572-0241.2004.41389_7.x ID - Leung2004 ER - TY - JOUR AU - Vonkeman, H. AU - Napel, C. AU - Rasker, H. AU - Laar, M. PY - 2004 DA - 2004// TI - Disseminated primary varicella infection during infliximab treatment JO - J Rheumatol VL - 31 ID - Vonkeman2004 ER - TY - JOUR AU - Elwir, S. M. AU - Shaffer, C. C. AU - Arvan, S. W. AU - Kuperman, E. F. PY - 2013 DA - 2013// TI - Disseminated varicella zoster virus infection with encephalitis in a UC patient receiving infliximab JO - Gastroenterol Hepatol (NY) VL - 9 ID - Elwir2013 ER - TY - JOUR AU - Miyagi, T. AU - Yamaguchi, S. AU - Yamamoto, Y. AU - Ohira, A. AU - Yasumura, R. AU - Nakasone, N. PY - 2014 DA - 2014// TI - Varicella zoster virus encephalopathy in a patient with psoriatic arthritis treated with anti-TNFα agents JO - Eur J Dermatol VL - 24 ID - Miyagi2014 ER - TY - JOUR AU - Buccoliero, G. AU - Lonero, G. AU - Romanelli, C. AU - Loperfido, P. AU - Resta, F. PY - 2010 DA - 2010// TI - Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor-alpha agent in a psoriatic arthritis patient JO - New Microbiol VL - 33 ID - Buccoliero2010 ER - TY - JOUR AU - Lee, D. H. AU - Kim, H. S. AU - Song, Y. W. AU - Cho, K. H. PY - 2007 DA - 2007// TI - Development of varicella during adalimumab therapy JO - J Eur Acad Dermatol Venereol VL - 21 ID - Lee2007 ER - TY - JOUR AU - Becart, S. AU - Segaert, S. PY - 2008 DA - 2008// TI - Recurrent varicella in an adult psoriasis patient treated with etanercept JO - Dermatology VL - 217 UR - https://doi.org/10.1159/000149311 DO - 10.1159/000149311 ID - Becart2008 ER - TY - JOUR AU - Heininger, U. AU - Seward, J. F. PY - 2006 DA - 2006// TI - Varicella JO - Lancet VL - 368 UR - https://doi.org/10.1016/S0140-6736(06)69561-5 DO - 10.1016/S0140-6736(06)69561-5 ID - Heininger2006 ER - TY - JOUR AU - Hall, S. AU - Maupin, T. AU - Seward, J. AU - Jumaan, A. O. AU - Peterson, C. AU - Goldman, G. PY - 2002 DA - 2002// TI - Second varicella infections: are they more common than previously thought? JO - Pediatrics VL - 109 UR - https://doi.org/10.1542/peds.109.6.1068 DO - 10.1542/peds.109.6.1068 ID - Hall2002 ER - TY - JOUR AU - Johnson, J. A. AU - Bloch, K. C. AU - Dang, B. N. PY - 2011 DA - 2011// TI - Varicella reinfection in a seropositive physician following occupational exposure to localized zoster JO - Clin Infect Dis VL - 52 UR - https://doi.org/10.1093/cid/cir033 DO - 10.1093/cid/cir033 ID - Johnson2011 ER - TY - JOUR AU - Straus, S. E. AU - Ostrove, J. M. AU - Inchauspé, G. AU - Felser, J. M. AU - Freifeld, A. AU - Croen, K. D. PY - 1988 DA - 1988// TI - NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention JO - Ann Intern Med VL - 108 UR - https://doi.org/10.7326/0003-4819-108-2-221 DO - 10.7326/0003-4819-108-2-221 ID - Straus1988 ER - TY - JOUR PY - 2014 DA - 2014// TI - Varicella and herpes zoster vaccines JO - WHO Position Paper VL - 89 ID - ref21 ER - TY - STD TI - European Medicines Agency. Humira. Summary of product characteristics. 2015. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000481/WC500050870.pdf. Accessed 20 Oct 2018. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000481/WC500050870.pdf ID - ref22 ER - TY - STD TI - US Food and Drug Administration: Humira. Highlights of prescribing information 2008. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125057s114lbl.pdf. Accessed 20 Oct 2018. UR - https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125057s114lbl.pdf ID - ref23 ER -